Contact
searchSearch
HMP Global

News

Press Release
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center Hosts International Conference on Complex Cardiac Arrhythmias
05/08/2024

Texas Cardiac Arrhythmia Institute Press Release 

Texas Cardiac Arrhythmia Institute Pr...
AUSTIN, Texas—On April 18-19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center hosted its seventh international symposium on complex arrhythmias, EPLive 2024. This year’s event included 1,000 registered...
AUSTIN, Texas—On April 18-19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center hosted its seventh international symposium on complex arrhythmias, EPLive 2024. This year’s event included 1,000 registered...
AUSTIN, Texas—On April 18-19,...
05/08/2024
EP Lab Digest
Hypertrophic Cardiomyopathy
American College of Cardiology, American Heart Association Issue New Guideline for Evaluation and Management of People With HCM
05/08/2024

American College of Cardiology and American Heart Association News

American College of Cardiology and Am...
The guideline reiterates the importance of collaborative decision-making with patients who have HCM and provides updated recommendations for the most effective treatment pathways for adult and pediatric patients.
The guideline reiterates the importance of collaborative decision-making with patients who have HCM and provides updated recommendations for the most effective treatment pathways for adult and pediatric patients.
The guideline reiterates the...
05/08/2024
Cath Lab Digest
HRS news
Press Release
Thryv Therapeutics to Present Preclinical Data of SGK1 Inhibition in Models of Drug-Induced QT Prolongation at Heart Rhythm 2024
05/07/2024

Thryv Therapeutics Press Release

Thryv Therapeutics Press Release ...
Montreal, Quebec – May 7, 2024 – Thryv Therapeutics Inc., a biotechnology company pioneering precision treatment to treat indications including Congenital Long QT Syndrome, atrial fibrillation, and heart failure, today announced a poster...
Montreal, Quebec – May 7, 2024 – Thryv Therapeutics Inc., a biotechnology company pioneering precision treatment to treat indications including Congenital Long QT Syndrome, atrial fibrillation, and heart failure, today announced a poster...
Montreal, Quebec – May 7, 2024 –...
05/07/2024
EP Lab Digest
Press Release
Medtronic receives approval for Symplicity Spyral™ Renal Denervation System in China
05/06/2024

Medtronic Press Release 

Medtronic Press Release 
Symplicity Spyral is the first renal denervation technology to be approved by the National Medical Products Administration; new, innovative, minimally invasive procedure uses radiofrequency energy to help reduce high blood pressure
Symplicity Spyral is the first renal denervation technology to be approved by the National Medical Products Administration; new, innovative, minimally invasive procedure uses radiofrequency energy to help reduce high blood pressure
Symplicity Spyral is the first...
05/06/2024
EP Lab Digest
Press Release
Edgewise Therapeutics Doses First Patient in Phase 2 CIRRUS-HCM Trial of EDG-7500 in Obstructive Hypertrophic Cardiomyopathy (HCM)
05/06/2024

Edgewise Therapeutics Press Release

Edgewise Therapeutics Press Release ...
BOULDER, Colo. -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced the dosing of the first patient in the Phase 2 CIRRUS-HCM trial of EDG-7500. EDG-7500 is a novel oral,...
BOULDER, Colo. -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced the dosing of the first patient in the Phase 2 CIRRUS-HCM trial of EDG-7500. EDG-7500 is a novel oral,...
BOULDER, Colo. -- Edgewise...
05/06/2024
EP Lab Digest
Press Release
Heart Failure 2024: Why Are Women Less Treated Than Men? What is AI’s Role in Diagnosis?
05/06/2024

European Society of Cardiology Press Release

European Society of Cardiology Press ...
Cutting edge science and stimulating discussions in heart failure management are in store at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC). Heart Failure is the annual congress of the Heart Failure...
Cutting edge science and stimulating discussions in heart failure management are in store at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC). Heart Failure is the annual congress of the Heart Failure...
Cutting edge science and...
05/06/2024
EP Lab Digest
HRS news
HRS News
Help Save Lives: Heart Rhythm Society Provides AED and CPR Training to Boston Area Hotel and Convention Center Staff
05/06/2024
As the Heart Rhythm Society (HRS) prepares to kick off its annual conference on May 16, 2024, in Boston, MA, it is providing seven life-saving training sessions for Boston hotels, Meet Boston’s convention centers, and supporting vendors.
As the Heart Rhythm Society (HRS) prepares to kick off its annual conference on May 16, 2024, in Boston, MA, it is providing seven life-saving training sessions for Boston hotels, Meet Boston’s convention centers, and supporting vendors.
As the Heart Rhythm Society...
05/06/2024
EP Lab Digest
EPLD news
Press Release
Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024
05/02/2024
Milestone® Pharmaceuticals Inc., announces upcoming data presentations on etripamil at Heart Rhythm 2024.
Milestone® Pharmaceuticals Inc., announces upcoming data presentations on etripamil at Heart Rhythm 2024.
Milestone® Pharmaceuticals Inc.,...
05/02/2024
EP Lab Digest
Press Release
URMC Heart Researchers Launch $27M ICD Study
05/01/2024

University of Rochester Medical Center Press Release

University of Rochester Medical Cente...
Heart researchers at University of Rochester Medical Center (URMC) will launch a $27 million study that may substantially decrease the use of implantable cardioverter defibrillators (ICD) for patients with heart failure, because of advances...
Heart researchers at University of Rochester Medical Center (URMC) will launch a $27 million study that may substantially decrease the use of implantable cardioverter defibrillators (ICD) for patients with heart failure, because of advances...
Heart researchers at University...
05/01/2024
EP Lab Digest
Press Release
Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
05/01/2024

Orchestra BioMed Holdings Press Release 

Orchestra BioMed Holdings Press Relea...
NEW HOPE, Pa., April 30, 2024 -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today...
NEW HOPE, Pa., April 30, 2024 -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today...
NEW HOPE, Pa., April 30, 2024 --...
05/01/2024
EP Lab Digest
EPLD Nov cover 2026

Current Issue

November 2026
Volume 26
Issue 11
Current Issue
Issue Archive

About Us

 EP Lab Digest, the official media partner of the Western Atrial Fibrillation Symposium, is dedicated to serving as an educational resource and a trusted voice for electrophysiology professionals.

Find out more about Western Atrial Fibrillation Symposium and register here:

Western AFIB logo

Stay in the know.

EP Lab Digest Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use